http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150049695-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87d40fb4785f5b3f1a4dba8c69339d1a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
| filingDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28163e236c965b897eba1a61352e56c |
| publicationDate | 2015-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150049695-A |
| titleOfInvention | Flavokawain derivative or pharmaceutically acceptable salt thereof having inhibitory activity on Hsp90 and medical use thereof |
| abstract | The present invention relates to a flavone wine derivative having Hsp90 inhibitory activity, a pharmaceutically acceptable salt thereof and a medicinal use thereof, wherein the flavone wine derivative is excellent in inhibiting effect of Hsp90, Induce the degradation of Hsp90 client protein causing neurodegenerative diseases, and thus can be useful as medicines or health foods for the treatment or prevention of Hsp90 mediated diseases such as cancer diseases or neurodegenerative diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115433073-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021068533-A1 |
| priorityDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.